Comparison between Empyrean Cashews IPO and Global Longlife Hospital IPO.
Empyrean Cashews IPO is a SME Fixed Price IPO proposed to list at NSE SME while Global Longlife Hospital IPO is a SME Fixed Price proposed to list at BSE SME.
| Empyrean Cashews IPO | Global Longlife Hospital IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Systematix Corporate Services Ltd. | Interactive Financial Services Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Systematix Shares & Stocks (India) Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Empyrean Cashews IPO is up to ₹18.44 Cr whereas the issue size of the Global Longlife Hospital IPO is up to ₹46.54 Cr. The final issue price of Empyrean Cashews IPO is ₹37.00 per share and of Global Longlife Hospital IPO is ₹140.00 per share.
| Empyrean Cashews IPO | Global Longlife Hospital IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹37.00 per share | ₹140.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1000 shares |
| Fresh Issue Size | 49,83,000 shares | 33,24,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.44 Cr | up to ₹46.54 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 49,83,000 shares | 33,24,000 shares |
| Issue Size Total (Amount) | up to ₹18.44 Cr | up to ₹46.54 Cr |
Empyrean Cashews IPO opens on Mar 21, 2022, while Global Longlife Hospital IPO opens on Apr 21, 2022. The closing date of Empyrean Cashews IPO and Global Longlife Hospital IPO is Mar 23, 2022, and Apr 25, 2022, respectively.
| Empyrean Cashews IPO | Global Longlife Hospital IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 21, 2022 | Apr 21, 2022 |
| Issue Close | Mar 23, 2022 | Apr 25, 2022 |
| Basis Of Allotment (Tentative) | Mar 28, 2022 | |
| Initiation of Refunds (Tentative) | Mar 30, 2022 | |
| Credit of Share (Tentative) | Mar 30, 2022 | |
| Listing date (Tentative) | Mar 31, 2022 | May 04, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Empyrean Cashews IPO P/E ratio is 25.69, as compared to Global Longlife Hospital IPO P/E ratio of 38.04.
| Empyrean Cashews IPO | Global Longlife Hospital IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 56.99 | 81.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 41.88 | 54.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 25.69 | 38.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹73.24 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Empyrean Cashews IPO Retail Individual Investors (RII) are offered 24,91,500 shares while in Global Longlife Hospital IPO retail investors are offered 24,91,500 shares. Qualified Institutional Buyers (QIB) are offered in Empyrean Cashews IPO and in Global Longlife Hospital IPO.
| Empyrean Cashews IPO | Global Longlife Hospital IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 2,64,000 shares | 1,76,000 shares |
| QIB | ||
| NII | 24,91,500 shares | 16,62,000 shares |
| RII | 24,91,500 shares | 16,62,000 shares |
| Employee | ||
| Others | ||
| Total | 49,83,000 shares | 33,24,000 shares |
Empyrean Cashews IPO subscribed 2.28x in total, whereas Global Longlife Hospital IPO subscribed 1.50x.
| Empyrean Cashews IPO | Global Longlife Hospital IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.92x | 1.60x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.63x | 1.40x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.28x | 1.50x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
